Titelia

Funds holding Scinai Immunotherapeutics Ltd

ISIN US09073Q3039 · Israel · LEI 549300VWSLMYAANYZ711

Fund holders
1
Of which ETFs
1 0 other funds
Value held
1.1 $

A single tracked fund declares this company. So these figures do not say who owns it.

FundSharesValueWeight in fund
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF SPDR INDEX SHARES FUNDS 21.1 $as of Mar 31, 2026 ↗

Download this table: CSV, JSON

Report an error

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterHoldersChangeSharesChange
2026Q21020.0 %
2026Q11020.0 %
2025Q41020.0 %
2025Q31020.0 %
2025Q21020.0 %
2025Q11-12-98.6 %
2024Q4201390.0 %
2024Q32139

Institutional managers

4 managers declare this company to the SEC (Form 13F).

ManagerSharesValue
XTX Topco Ltd24,04113.3K $as of Mar 31, 2026
RHUMBLINE ADVISERS1,8781K $as of Mar 31, 2026
UBS Group AG919524 $as of Mar 31, 2026
MORGAN STANLEY5833 $as of Mar 31, 2026
Cite this page

Titelia. "Funds holding Scinai Immunotherapeutics Ltd". https://titelia.com/en/stocks/scinai-immunotherapeutics-ltd-US09073Q3039